NCT04488081: I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
- State
- Under way
- Phase
- Phase 2
- People
- 1,500 planned
- Started
- 31 Jul 2020
- Primary completion
- 31 Jul 2028
- Arms
- Celecoxib/famotidine + Standard of Care (CLOSED)
- Results
- None posted
- 27 Jul 2020: Trial registered
- 31 Jul 2020: Trial started